Rodger Allen has been training in sand dunes to prepare for his desert challenge.

Three phase 3 prostate cancer results from ESMO 2026 cover long-term survival with abiraterone in metastatic disease, Erleada before and after surgery, and an update on Truqap for PTEN-deficient ...

A study of 302 patients found prostate artery embolization significantly improved urinary symptoms, objective parameters, and ...

The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy ...

U.S. pharmaceutical company Johnson & Johnson (J&J) is conducting clinical trials for the new prostate cancer (prostate gland ...

Johnson & Johnson (J&J) said that an early-stage trial of JNJ-6143 (previously HLD-0915) found that the novel oral Regulated ...

C, explains why a prostate cancer diagnosis should be seen as a change in direction, not an ending, and how patients can lean ...

The new prostate cancer test that could predict disease 15 years in advance - A major study found clear biological differences between men who later developed prostate cancer and those who did not ...

After a friend divulged perhaps too much information, humorist David Sedaris considers the ramifications of over-sharing – ...

A new alpha-emitting radiopharmaceutical therapy (RPT) for advanced prostate cancer was well tolerated, with no dose-limiting ...

AstraZeneca has punted a pair of early-phase prostate cancer progra | AstraZeneca has punted a pair of early-phase prostate ...

A study by Leicester researchers shows that the timing of radiotherapy treatment may be as important as how it is given for ...